Trials / Completed
CompletedNCT00132717
A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)
An Open-Label, Multicenter Study to Assess the Efficacy of Switching to a Combination Tablet Ezetimibe/Simvastatin 10mg/40mg, Compared to Doubling the Dose of Statin in Patients Hospitalized With a Coronary Event
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 450 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effect of an investigational cholesterol-lowering drug in patients who are currently taking an approved medication for hypercholesterolemia (high cholesterol levels) and have been hospitalized for a heart problem.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0653A (ezetimibe [+] simvastatin) | |
| DRUG | Comparator: atorvastatin | |
| DRUG | Comparator: fluvastatin | |
| DRUG | Comparator: lovastatin | |
| DRUG | Comparator: pravastatin | |
| DRUG | Comparator: rosuvastatin | |
| DRUG | Comparator: simvastatin |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2005-08-22
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00132717. Inclusion in this directory is not an endorsement.